• LAST PRICE
    0.3750
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.3000/ 1
  • Ask / Lots
    0.4400/ 1
  • Open / Previous Close
    0.0000 / 0.3750
  • Day Range
    ---
  • 52 Week Range
    Low 0.0250
    High 1.5900
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaBMND
Biomind Labs Inc
28.1M
-14.1x
---
CanadaAPS
Aptose Biosciences Inc
26.7M
-0.2x
---
CanadaHUGE
FSD Pharma Inc
26.7M
-0.9x
---
CanadaTTI
Thiogenesis Therapeutics Corp
34.1M
-8.3x
---
CanadaHBP
Helix Biopharma Corp
48.2M
-7.7x
---
CanadaBUX
BioMark Diagnostics Inc
27.3M
-15.8x
---
As of 2024-04-29

Company Information

Biomind Labs Inc. is a Canada-based biotech research and development company. The Company is primarily engaged in biotech platform that integrates biology, chemistry, medicine, neuroscience, technology, intellectual property and pharma grade production with special focus on scientific research, clinical trials and in jurisdictions that open a fast track in the molecule to market lifecycle. Through its acceleration platform, it is developing novel pharmaceutical formulations of the main psychedelic molecules, N, N-dimethyltryptamine (DMT), 5-MeO-DMT, and mescaline for treating a range of therapeutic indications. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, the Company is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class. DMT Program is a serotonergic psychedelic.

Contact Information

Headquarters
181 Bay Street , Suite 1800, Brookfield PlaceTORONTO, ON, Canada M5J 2T9
Phone
800-439-5136
Fax
---

Executives

Chairman of the Board
Ravi Sood
Chief Executive Officer, Director
Alejandro Antalich
Chief Financial Officer, Director
Oscar Leon
Chief Scientific Officer
Paola Dellavalle
Chief Legal Officer
Juan Presa

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$28.1M
Revenue (TTM)
$0.00
Shares Outstanding
74.8M
Biomind Labs Inc does not pay a dividend.
Beta
---
EPS
$-0.03
Book Value
$0.00
P/E Ratio
-14.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.